High-Dose VE303 Prevents Recurrent Clostridioides Difficile Infection

WEDNESDAY, April 19, 2023 (HealthDay News) -- For adults with laboratory-confirmed Clostridioides difficile infection (CDI) at high risk for recurrence, high-dose VE303, a defined bacterial consortium of eight strains of commensal Clostridia, prevents recurrent CDI, according to a study published online April 15 in the Journal of the American Medical Association to coincide with the

Related Keywords

Canada ,United States ,Calgary ,Alberta ,Denmark ,Copenhagen ,Køavn ,American ,Thomas Louie ,University Of Calgary ,Foothills Medical Centre ,European Congress ,Journal Of The American Medical Association ,Healthday News ,American Medical Association ,Clinical Microbiology ,Infectious Diseases ,Vedanta Biosciences ,